RE: Baricitinib28 May 2025 14:00
I totally concur SOG. I am quite clear in my own mind that Sareum has not changed it's stated strategy but has, in fact, broadened the pipeline and potentially enhanced any value for future deals whether that be License or being taken over. I would readily acknowledge that the silence is frustrating but the timeline advice for the commencement of the further Tox study is still in play until Friday.
What I would add is that, for those who doubt, nothing has changed and it is worth pointing out that if there was anything amiss then that would also require a RNS - I am sure we will get to know quite soon.
For those scoffing at the idea of a NDA being in place I can assure you that total comms blackout is quite the norm as nobody would want to risk any sort of deal collapse due to unguarded communication or statements. The existence of any NDA is confidential in itself. If one is in place any breach of an NDA could undermine months of negotiations.
I have stated before (many times) that any third party will have to satisfy it's own Scientific team, BoD and shareholders so Sareum BoD will understand that also. It would suit any third party to buy time and stifle advancement in order to get best value from any potential deal. I am not stating a deal is imminent but just stating a couple of factors in play if negotiations are being held. Whatever the situation, the next RNS will, hopefully, be positive and take us further forwards.